Altimmune, Inc. (ALT)
4.225
-0.02
(-0.35%)
USD |
NASDAQ |
Jan 20, 16:00
4.25
+0.02
(+0.59%)
Pre-Market: 08:11
Altimmune Free Cash Flow: -66.66M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Viking Therapeutics, Inc. | -224.58M |
| CorMedix, Inc. | 74.42M |
| Actinium Pharmaceuticals, Inc. | -25.04M |
| Aldeyra Therapeutics, Inc. | -40.08M |
| Seres Therapeutics, Inc. | -23.37M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.90M |
| Cash from Investing (Quarterly) | -149.32M |
| Cash from Financing (Quarterly) | 39.35M |
| Free Cash Flow Per Share (Quarterly) | -0.133 |
| Free Cash Flow to Equity (Quarterly) | -11.95M |
| Free Cash Flow to Firm (Quarterly) | -11.40M |
| Free Cash Flow Yield | -19.86% |